HiTS Seminar: Bissan Al-Lazikani, PhD, 10:00 am, Tuesday, March 20, 2018

Bissan Al-Lazikani, PhD

Head of Data Science, Institute of Cancer Research, UK


Integrative Big Data for Cancer Drug Discovery and Individualised Therapy

Advances in technology are enabling unprecedented systematic mapping of disease mechanisms. To fully exploit this wealth of knowledge in advancing cancer therapy, we must develop integrative ‘Big Knowledge’ approaches to inform drug discovery and adaptive cancer therapy. I will describe with real world use cases how integrative computational methodologies are underpinning target selection and drug discovery, drug combinations and adaptation of therapy.


10:00 am – 11:00 am
Tuesday, March 20, 2018

Harvard Medical School
200 Longwood Avenue
Warren Alpert Bldg, 5th Floor, Room 563
Boston, MA 02115

Hosted by Adam Palmer, Ph.D.

Posted by Chris Bird on at .
Filed under News Article.